Polyester Segment to Dominate Europe Blood Filter Market during 2019–2028

According to a new market research study on “Europe Blood Filter Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Product, Material, Application, and End User,” is expected to reach US$ 1,45,156.91 thousand by 2028 from US$ 1,12,166.63 thousand in 2021. The market is estimated to grow at a CAGR of 3.8% from 2021 to 2028. Surge in number of blood transfusion procedures is the major factor driving the growth of the Europe blood filter market. However, product recalls may hinder the growth of Europe blood filter market. The report provides trends prevailing in the Europe blood filter market along with the drivers and restraints pertaining to the market growth.

European countries were hit due to the exponential increase in COVID-19 cases. According to the European Center for Disease Prevention and Control (ECDC), social restrictions were reintroduced in the UK, Spain, Italy, and Ireland after the beginning of the second wave of pandemic in these countries. Spain, Italy, Germany, France, and the UK are among the worst-hit European countries. The blood filter market stakeholders were losing their businesses due to the temporary shutdown of industries in the region. In 2019, the European Commission's (EC) assessment of the EU Blood Directive concluded that current regulations are insufficient to ensure an adequate and sustainable blood supply. According to the European Blood Alliance and the ECDC, European national and regional blood services reported an average decrease of 9% (median, range 1–27%) in blood and blood components collected in March and April 2020 compared to the corresponding period in 2019. As a result, there was an overall decrease of 12% in blood components distributed to hospitals (range 1–18%). At the beginning of the pandemic, several centers in Italy, Spain, and Greece reported a 32%, 11–49%, and 25–60% decrease in. In the UK, the RBC units received by blood collection centers dropped by ~30% in March 2020, which has leveled off at ~10% by May 2020. The demand for transfusions was further decreased due to delays in cancer treatments, and reduced road accidents and subsequent trauma cases. In 2019, the Seraph 100 Microbind Affinity Blood Filter from ExThera Medical Corporation was approved for its sale in Europe. The product was approved by the FDA for emergency use in COVID-19 patients admitted to the intensive care unit with confirmed or imminent respiratory failure. The blood is cleaned with dialysis by pumping it through the filter. The Seraph is indicated for reducing pathogens in bloodstream, such as SARS-CoV-2, MRSA, and other drug-resistant bacteria.

The Europe blood filter market is segmented into product, application, material, end user, and country. The Europe blood filter market, by product, is segmented into 40 Microns and 70 Microns, 100 Microns and 170 Microns, and others. The 100 microns to 170 microns segment held the largest share of the market in 2021. The Europe blood filter market, by material, is segmented into polycarbonate, polyester, ABS, and others. The polyester segment held the largest share of the market in 2021. The Europe blood filter market, by application, is segmented into blood processing and blood transfusion. The blood transfusion segment held the largest share of the market in 2021. On the basis of blood transfusion, the market is further segmented into whole blood, red cell, and plasma and platelet filtration. The plasma and platelet filtration segment accounts for largest market share in the 2021. Based on end user, the Europe blood filter market is segmented blood banks, hospitals, and others. The blood banks segment held the largest share of the market in 2021. Similarly, based on country, the market is bifurcated into Germany, France, UK, Italy, Spain, and rest of Europe. The rest of Europe contributed a substantial share in 2021. 

Asahi Kasei Corporation; Fresenius Kabi AG; Haemonetics Corporation; Infomed SA; KANEKA CORPORATION; Macopharma; Nanjing Shuangwei Biotechnology Co., Ltd.; Sefar AG; and Shandong Zhongbaokang Medical Implements Co., Ltd are among the leading companies in the Europe Blood Filter Market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2020, ExThera Medical’s Seraph 100 Microbind Affinity Filter (Seraph 100) is distributed in Europe by Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases. The two companies signed a co-marketing and distribution agreement earlier this year.

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com